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Abstract 
Background: Excess vitamin A is associated with decreased cortical bone and in-
creased risk of fractures in humans. The aim of the present thesis was to assess the 
importance of vitamin A on the skeleton and bone cells in in vivo animal studies and 
mechanistic in vitro experiments. In vivo, we used clinically relevant doses of vitamin A 
to investigate its effects on bone after prolonged administration and on the anabolic 
bone response to mechanical loading. In vitro, we aimed to determine how retinoids 
affect inflammatory- and physiologically-induced osteoclast formation and how retin-
oids affect periosteal osteoclast progenitors. 
 
Methods: In vivo, mice were fed diets containing clinically relevant doses of vitamin A 
for durations of 4 and 10 weeks and prior to and during 2-week mechanical loading of 
the tibia. In vitro, we investigated the effects of retinol on human monocytes and mouse 
bone marrow macrophages induced to form osteoclasts by physiological and inflam-
matory cytokines, and on periosteal cell cultures.  
 
Results: In vivo, we found that clinically relevant doses of vitamin A are able to reduce 
cortical bone mass by means of increased resorption and to decrease the anabolic bone 
response to mechanical loading due to reduced bone formation. In vitro, our results 
indicate that all-trans retinoic acid (ATRA), the active metabolite of retinol, inhibits 
physiologically- and inflammatory-induced osteoclastogenesis, however, in mouse per-
iosteal bone cell cultures, the addition of ATRA enhances osteoclastogenesis. 
 
Conclusion: Our results demonstrate the importance of vitamin A status to bone 
health.  Fortification of food with vitamin A and vitamin A supplementation should be 
re-examined as vitamin A status may be a risk factor for secondary osteoporosis, a 
disease of decreased bone mass and increased risk of fractures.  
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